2(1H)-Quinoxalinone,3-(3,6-dimethyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8-yl)- (101073-87-4)

Identification
Name:	2(1H)-Quinoxalinone,3-(3,6-dimethyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8-yl)-
CAS:	101073-87-4
Molecular Formula:	C₁₄H₁₁N₇O
Molecular Structure:
Properties
Safety Data

Other Product

2(1H)-Quinoxalinone,3-(5,8-dihydro-3,6-dimethyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8-yl)-
2(1H)-Quinoxalinone, 3-(3-methyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8-yl)-
2(1H)-Quinoxalinone,3-(5,8-dihydro-3-methyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8-yl)-
2(1H)-Quinoxalinone,6-chloro-3-[5-(hydroxymethyl)-1-(4-methylphenyl)-1H-pyrazol-3-yl]-
2(1H)-Quinoxalinone,3-[1-(4-bromophenyl)-5-(hydroxymethyl)-1H-pyrazol-3-yl]-6-chloro-
2(1H)-Quinoxalinone,6-chloro-3-[5-(hydroxymethyl)-1-(4-iodophenyl)-1H-pyrazol-3-yl]-
2(1H)-Quinoxalinone,3-[5-[(acetyloxy)methyl]-1-(4-methylphenyl)-1H-pyrazol-3-yl]-6-chloro-
2(1H)-Quinoxalinone,3-[5-[(acetyloxy)methyl]-1-(4-methoxyphenyl)-1H-pyrazol-3-yl]-6-chloro-
2(1H)-Quinoxalinone,3-[5-[(acetyloxy)methyl]-1-(4-nitrophenyl)-1H-pyrazol-3-yl]-6-chloro-
2(1H)-Quinoxalinone,4-[[(5,7-dimethyl-1,2,4-triazolo[4,3-a]pyrimidin-3-yl)thio]acetyl]-3,4-dihydro-(9CI)
1,2,4-Triazolo[3,4-f][1,6]naphthyridine, 9-phenyl-8-[4-[[4-[5-(2-pyridinyl)-1H-1,2,4-triazol-3-yl]-1
2(1H)-Quinoxalinone,3-[[8-methyl-4-(4-methylphenyl)-1-isoquinolinyl]methyl]-
2(1H)-Quinoxalinone,3-[[8-fluoro-4-(4-fluorophenyl)-1-isoquinolinyl]methyl]-
2(1H)-Quinoxalinone,3-[5-[(acetyloxy)methyl]-1-(4-fluorophenyl)-1H-pyrazol-3-yl]-1-methyl-
2(1H)-Quinoxalinone,3-amino-1-methyl-, 4-oxide
2(1H)-Quinoxalinone,1-ethoxy-3-methyl-, 4-oxide
2(1H)-Quinoxalinone,1-hydroxy-3-methyl-, 4-oxide
2(1H)-Quinoxalinone, 3-[(4-phenyl-1-isoquinolinyl)methyl]-
2(1H)-Quinoxalinone, 3-(4-chlorophenyl)-1-phenyl-
2(1H)-Quinoxalinone, 3-(4-methoxyphenyl)-1-phenyl-